We used SPR to measure the affinity of NT4 binding to recombinant syndecans and glypicans, selected among those highly expressed by HT-29, PANC-1, MDA-MB-231, and MCF-7 cancer cell lines. The gene discussed is SDC1; the disease is cancer.